Frequently Asked Questions About RSV Immunization with Monoclonal Antibody for Children 19 Months and Younger

i

Frequently Asked Questions About RSV Immunization with Monoclonal Antibody for Children 19 Months and Younger

Supporting Files Public Domain

March 27, 2024
By National Center for Immunization and Respiratory Diseases (U.S.)

File Language:

English

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)
Content Notes:

Nirsevimab Indication, Dosage and Schedule -- Timing of Nirsevimab Administration -- Immunization Errors -- Nirsevimab and RSV infection -- Nirsevimab and Routine Childhood vaccines -- Special Populations and Situations -- Adverse Events After Nirsevimab Administration.
Subjects:

Antibodies, Monoclonal/therapeutic Use Child Child, Preschool Infant Respiratory Syncytial Virus, Human Respiratory Syncytial Virus Infections/prevention & Control Respiratory Syncytial Virus Vaccines
Document Type:

Webpage
Name as Subject:

Nirsevimab
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:bce01203439030f95bd2fc191a689b5f3d329ca35e19349bdd16d5377b39981d
Download URL:

https://stacks.cdc.gov/view/cdc/154507/cdc_154507_DS1.pdf
File Type:

[PDF - 476.55 KB ]

child-faqs.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.